Article
Optimizing Fingolimod Dosing in STZ-Induced Cognitive Impairment: Divergent Behavioral and Histopathological Responses Reveal a Narrow Neuroprotective Window
2025-12-18
Abstract excerpt
<title>Abstract</title> <p> <bold>Background/Objective:</bold> Fingolimod, an S1P receptor modulator, is neuroprotective and anti-inflammatory in animal models of neurodegenerative disorders; its optimal dosage regimen for cognitive dysfunction is yet to be defined. The impact of fingolimod on cognitive function, neuroinflammation, oxidative levels, as well as hippocampal morphology, was evaluated in the strept...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- a2cdf58f-937b-5393-a860-2f4678d38576
- DOI
- 10.21203/rs.3.rs-8382715/v1
